drugset / Trial / NCT02800746
Intravenous Iron Pre-treatment in Prognathic Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of the present study is to determine the impact of preoperative IV-iron (ferric carboxy maltose) supplementation on postoperative hematocrit values and allogenic blood transfusion amount in patients undergoing elective prognathic surgery.
Timeline
- Start
- 2018-06
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferric carboxymaltose | Other / unclassified | 15 mg/kg | Intravenous |
Indications
No indication recorded.